Takaisin Tulosta

Dyslipidemiat valtimoahtaumasairauden riskitekijänä ja perusteita hoitotavoitteille

Lisätietoa aiheesta
Timo Strandberg
27.10.2020

Kirjallisuutta

  1. Ference BA, Ginsberg HN, Graham I ym. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2017;38:2459-2472 «PMID: 28444290»PubMed
  2. Borén J, Chapman MJ, Krauss RM ym. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2020;: «PMID: 32052833»PubMed
  3. Cohen JC, Boerwinkle E, Mosley TH Jr ym. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006;354:1264-72 «PMID: 16554528»PubMed
  4. Berenson GS, Srinivasan SR, Bao W ym. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-6 «PMID: 9614255»PubMed
  5. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-8 «PMID: 3773199»PubMed
  6. Strandberg TE, Strandberg A, Rantanen K ym. Low cholesterol, mortality, and quality of life in old age during a 39-year follow-up. J Am Coll Cardiol 2004;44:1002-8 «PMID: 15337210»PubMed
  7. Strandberg TE, Kolehmainen L, Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia: a clinical review. JAMA 2014;312:1136-44 «PMID: 25226479»PubMed
  8. Collins R, Reith C, Emberson J ym. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016;388:2532-2561 «PMID: 27616593»PubMed
  9. Mach F, Baigent C, Catapano AL ym. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111-188 «PMID: 31504418»PubMed